THERAVANCE INC - COMMON STOCK (THRX)

CUSIP: 88338T104

Q4 2014 13F Holders as of 31 Dec 2014

Type / Class
Equity / COMMON STOCK
Total 13F shares
99,297,605
Share change
+3,771,325
Total reported value
$1,404,455,647
Put/Call ratio
316%
Price per share
$14.15
Number of holders
110
Value change
+$43,500,887
Number of buys
53
Number of sells
58

Quarterly Holders Quick Answers

What is CUSIP 88338T104?
CUSIP 88338T104 identifies THRX - THERAVANCE INC - COMMON STOCK in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of THERAVANCE INC - COMMON STOCK (THRX) as of Q4 2014

As of 31 Dec 2014, THERAVANCE INC - COMMON STOCK (THRX) was held by 110 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 99,297,605 shares. The largest 10 holders included BAUPOST GROUP LLC/MA, FMR LLC, IRIDIAN ASSET MANAGEMENT LLC/CT, VANGUARD GROUP INC, BlackRock Fund Advisors, OPPENHEIMER FUNDS INC, PERRY CORP, State Street Corp, Capital World Investors, and MANUFACTURERS LIFE INSURANCE COMPANY, THE. This page lists 110 institutional shareholders reporting positions in this security for the Q4 2014 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.